$APLT, $BIIB, $GILD, $LOGI, $STNE
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is the list for Friday, 28 February, as follows;
Applied Therapeutics Inc. (NASDAQ:APLT) was started with an Overweight rating and a 64 target price at Barclays. Its consensus target price was 50.67.
Biogen Inc. (NASDAQ:BIIB) was started with an Overweight rating and a 389 target price at Barclays.
Gilead Sciences Inc. (NASDAQ:GILD) was started with an Underweight rating and a 62 target price at Barclays. The stock closed up over 6% at 74.70 Wednesday, after starting trials here in the US to see if its drug can help cure the coronavirus. Shares finished at 72.66 Thursday.
Logitech International S.A. (NASDAQ:LOGI) was raised to Overweight from Neutral with a 48 target price at JPMorgan. Shares have consensus target price was 54.20.
StoneCo. Ltd. (NASDAQ:STNE) was raised to Overweight from Neutral and its target price was raised to 48 from 43 at JPMorgan. The 52-wk trading range is 23.15 – 45.72.
Have a terrific weekend
Latest posts by Paul Ebeling (see all)
- The Coronavirus has Not Put America’s Food Supply at Risk - April 5, 2020
- People Stay In, Wild Animals Come Out - April 5, 2020
- We Must Be Optimistic About the Long-Term Impact of the ‘Covid Economy’ - April 5, 2020